3rd Quarter - Report

WILLIAMS AND JENSEN, PLLC for ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB), repeal of Part D Non-interference Provision; CCMI Medicare Part B Demonstration.

LobbyistCovered position, as disclosed
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: Office of the Vice President of the United States; SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry, tax reform issues.

LobbyistCovered position, as disclosed
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of the Vice President of the United States

Health Issues HCR

21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in FY 2017 appropriations bills; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee Chronic Disease Initiative; Implementation of Precision Medicine Initiative; White House Cancer Moonshot; Legislation affecting the ESRD program.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.